NCT02758626 Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome Status COMPLETED Phase PHASE2
NCT02752373 A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization Status TERMINATED Phase N/A
NCT02741193 Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS) Status COMPLETED Phase NA
NCT02739282 Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs Status COMPLETED Phase NA
NCT02736162 Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy Status COMPLETED Phase N/A
NCT02727101 Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study. Status TERMINATED Phase PHASE4
NCT02726919 Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy Status UNKNOWN Phase PHASE4
NCT02726867 Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus Status WITHDRAWN Phase PHASE3
NCT02726074 Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization Status COMPLETED Phase PHASE4
NCT02710890 Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children. Status COMPLETED Phase PHASE2/PHASE3
NCT02700412 University of Alabama at Birmingham (UAB) Adult CBD Program Status COMPLETED Phase PHASE1
NCT02695537 University of Alabama at Birmingham (UAB) Pediatric CBD Program Status COMPLETED Phase PHASE1
NCT02694094 Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02679846 Safety of Antiepileptic Withdrawal in Long Term Video-EEG Monitoring Status COMPLETED Phase NA